www.bloomberg.com
Summarize this content to 100 words: Amgen Inc. exceeded fourth-quarter expectations on strong sales of its biggest medicines, and forecast 2026 performance that aligns with what Wall Street is anticipating, positive results for the company as it faces rising challenges from rivals.
Read More
